Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Optimization Phase of Fluid Therapy in the Critically Ill (the RESPONSE Trial)

NCT02860572 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT02860572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02860572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Optimization Phase of Fluid Therapy in the Critically Ill (the RESPONSE Trial)
Lead sponsor
Helsinki University Central Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2017
Completion date
December 10, 2020
Enrollment
130 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, critically ill, oliguria, sepsis